Given that plasma DPP4 activity at SPIDDM diagnosis was significantly correlated with UACR at the last outpatient clinic, we conducted a survival analysis during the follow-up of SPIDDM to assess if plasma DPP4 activity could serve as a marker for future DKD progression. Here, DPP4 is linked to diabetic kidney disease.